The genomics company develops treatment for diabetes and obesity.
The Incubator writes off its dotcom investments and goes bargain-hunting.
Foot and mouth could damage the outdoor leisure retailer’s planned MBO.
The private equity firm is in talks with Kingfisher but the two have yet to agree a price
Money for optics, media software, gardening retail and heart technology.
Old economy companies do the biggest deals and France bucks the trend.
Cammell Laird, the Merseyside shipbuilder, is not yet sunk.
Will it be the latest semi-captive PE firm to win independence?
Due diligence specialist Coba will boost PwC’s strategy division.
Venture capitalist takes a majority stake in Medicis, a biotech investor.